These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5533297)

  • 1. Twenty-four-hour urinary glucose levels during tolbutamide and glibenclamide therapy.
    Cohen H; Clyne JR
    Postgrad Med J; 1970 Dec; ():Suppl:50-2. PubMed ID: 5533297
    [No Abstract]   [Full Text] [Related]  

  • 2. Diurnal blood sugar levels and clinical experience during glibenclamide therapy.
    O'Sullivan DJ
    Postgrad Med J; 1970 Dec; ():Suppl:46-9. PubMed ID: 5533296
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of glibenclamide with chlorpropamide in newly diagnoeed maturity-onset diabetes.
    Gurling KJ
    Postgrad Med J; 1970 Dec; ():Suppl:66-9. PubMed ID: 5533301
    [No Abstract]   [Full Text] [Related]  

  • 4. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 5. Circadian variation of glucose, insulin and free fatty acids during the long-term use of oral hypoglycaemic agents in diabetes mellitus with special reference to glibenclamide.
    Hadden DR; Bhatia SK; Rigas A; Weaver JA; Montgomery DA
    Postgrad Med J; 1970 Dec; ():Suppl:53-7. PubMed ID: 5533298
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 7. [The development of sulfonylurea late resistance].
    Angeli I
    Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
    Marocco F; Patrito G
    Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical use of glibenclamide in diabetes mellitus.
    Luntz GR
    Postgrad Med J; 1970 Dec; ():Suppl:84-7. PubMed ID: 5533303
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma insulin and metabolic study on diabetes treated with glibenclamide.
    Anderson J; Coulson R; Grassick BD; Morris BA; Thomas WD; Tomlinson RW; Woodroffe F
    Postgrad Med J; 1970 Dec; ():Suppl:36-41. PubMed ID: 5533294
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with glibenclamide in three diabetic clinics.
    Brearley BF; Fawcitt RA; Hirst J
    Postgrad Med J; 1970 Dec; ():Suppl:60-2. PubMed ID: 5533300
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of a new hypoglycemic sulfonamide: glibenclamide].
    Guinet P; Tourniaire J; Ollier C
    Rev Lyon Med; 1970 Oct; 19(16):655-64. PubMed ID: 5532152
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of short-term effects of glibenclamide and chlorpropamide in newly diagnosed diabetics.
    FitzGerald MG; Malino JM
    Postgrad Med J; 1970 Dec; ():Suppl:57-9. PubMed ID: 5533299
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of glibenclamide and chlorpropamide. (Preliminary report).
    Hamblin JJ; Ismay G; Good MS; Wynne-Williams CJ; Baum G; Wilson IV
    Postgrad Med J; 1970 Dec; ():Suppl:92-4. PubMed ID: 5533305
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous tolbutamide test in secondary failure of antidiabetic sulfonamides].
    Canivet J; Jacotot B
    Sem Hop; 1968 Apr; 44(17):1147-51. PubMed ID: 4299418
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with glibenclamide in 300 diabetics.
    Beyer J; Schöffling K
    Postgrad Med J; 1970 Dec; ():Suppl:78-83. PubMed ID: 5500516
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of glibenclamide with other oral hypoglycaemic agents.
    Wetherill JH; Tunbridge RE
    Postgrad Med J; 1970 Dec; ():Suppl:88-91. PubMed ID: 5533304
    [No Abstract]   [Full Text] [Related]  

  • 18. Glibenclamide for secondary failure of other sulphonylureas.
    Stowers JM
    Postgrad Med J; 1970 Dec; ():Suppl;63-5. PubMed ID: 5500519
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].
    Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A
    Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of glibenclamide and chlorpropamide in the treatment of non-obese maturity onset diabetics.
    Johnston AT; Ireland JT
    Postgrad Med J; 1970 Dec; ():Suppl:98-100. PubMed ID: 5500517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.